Adaptive Biotechnologies Corp (NAS:ADPT)
$ 6.29 -0.15 (-2.33%) Market Cap: 950.41 Mil Enterprise Value: 791.33 Mil PE Ratio: 0 PB Ratio: 4.25 GF Score: 78/100

Adaptive Biotechnologies Corp at Bank of America Global Healthcare Conference Transcript

May 10, 2023 / 12:00AM GMT
Release Date Price: $7.12 (+1.57%)
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

Good afternoon, everyone. Welcome to Bank of America's 2023 Healthcare Conference coming to you live from the fabulous Encore Hotel in Las Vegas. I'm Derik De Bruin, the Senior Life Sciences, Diagnostics and Tools Analyst for Bank of America. And it is my great pleasure to introduce our next company, Adaptive Biotechnologies. And with us is Chad Robins, Co-Founder and CEO and Chairman; and Tycho Peterson, CFO. So, welcome, gentlemen. Thanks for being here. Thanks for schlepping out to Las Vegas.

Questions & Answers

Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

Big news this morning. You want to just get straight to that. And talk about the Genentech news and in terms of -- along with it or not. I mean we can...

Chad M. Robins
Adaptive Biotechnologies Corporation - Co-Founder, CEO & Chairman

Yes. I'm happy to talk about that, Derik. And first of all, thank you, and thank you to BofA for having us out

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot